Position in DXCM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,725,667
+$241,209 QoQ
Shares Held
55,318
-0.3% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#306
of 966 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SHELTON CAPITAL MANAGEMENT holds $23,257,676 across 12 Medical Devices names. DXCM ranks #2 (16.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
232,053 | $9,904,022 | |
| 2 | DXCM |
Dexcom Inc
This page
|
55,318 | $3,725,667 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
50,972 | $3,262,717 | |
| 4 | ABT |
Abbott Laboratories
|
27,256 | $2,473,209 | |
| 5 | MDT |
Medtronic plc
|
18,374 | $1,437,398 | |
| 6 | SYK |
Stryker Corp
|
1,823 | $573,953 | |
| 7 | LIVN |
LivaNova PLC
|
5,630 | $462,954 | |
| 8 | PEN |
Penumbra Inc
|
1,301 | $410,790 |
All Filings in DXCM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,725,667 | 55,318 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,484,458 | 55,485 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,743,467 | 56,403 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,102,607 | 46,108 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $5,448,554 | 62,419 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,414,333 | 64,641 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,162,683 | 66,384 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,449,377 | 66,369 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,708,002 | 50,344 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,698,655 | 48,296 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,902,837 | 47,569 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,060,136 | 43,517 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,392,086 | 34,177 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,816,280 | 32,848 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,450,196 | 30,468 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,981,590 | 37,020 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,668,174 | 35,800 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,578,820 | 8,950 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $4,805,702 | 8,950 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,714,480 | 8,621 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,594,913 | 8,419 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $3,025,704 | 8,419 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $2,827,988 | 7,649 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,031,539 | 7,354 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,981,311 | 7,354 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||